Blog
RSS FeedPosted by Michael Wonder on 03 Aug 2017
FDA approves first treatment for certain types of poor-prognosis acute myeloid leukaemia
3 August 2017 - The U.S. FDA today approved Vyxeos for the treatment of adults with two types of acute myeloid ...
Posted by Michael Wonder on 03 Aug 2017
U.S. FDA approves expanded labeling for Epclusa (sofosbuvir/velpatasvir) for the treatment of chronic hepatitis C in patients co-infected with HIV
1 August 2017 - New data for first approved pan-genotypic once-daily single tablet regimen for chronic hepatitis C virus infection. ...
Posted by Michael Wonder on 03 Aug 2017
US FDA accepts regulatory submission for acalabrutinib and grants priority review
2 August 2017 - AstraZeneca and its haematology research and development centre of excellence, Acerta Pharma, today announced that the ...
Posted by Michael Wonder on 02 Aug 2017
Senate plans to vote on FDA user fees legislation this week, senators say
1 August 2017 - The Senate will vote this week on a key legislative priority for the pharmaceutical industry and ...
Posted by Michael Wonder on 02 Aug 2017
The generic drug industry has brought huge cost savings. That may be changing.
1 August 2017 - A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: ...
Posted by Michael Wonder on 02 Aug 2017
Medicare issues projected drug premiums for 2018
2 August 2017 - This week, the Centers for Medicare & Medicaid Services announced that the average basic premium for ...
Posted by Michael Wonder on 02 Aug 2017
FDA approves treatment for chronic graft versus host disease
2 August 2017 - The U.S. FDA today expanded the approval of Imbruvica (ibrutinib) for the treatment of adult patients with ...
Posted by Michael Wonder on 02 Aug 2017
Rising prices of targeted oral anti-cancer medications and associated financial burden on Medicare beneficiaries
1 August 2017 - The high cost of oncology drugs threatens the affordability of cancer care. ...
Posted by Michael Wonder on 02 Aug 2017
Republicans in Congress bypass Trump to shore up health law
1 August 2017 - Congressional Republicans moved on Tuesday to defuse President Trump’s threat to cut off critical payments to ...
Posted by Michael Wonder on 02 Aug 2017
FDA approves Kalydeco (ivacaftor) for more than 600 people ages 2 and older with cystic fibrosis who have certain residual function mutations
1 August 2017 - Vertex Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Kalydeco (ivacaftor) ...
Posted by Michael Wonder on 02 Aug 2017
AiCuris granted fast track designation by U.S. FDA for oral pritelivir for treatment of HSV infections in immunocompromised adults
1 August 2017 - AiCuris today announced that the Company has been granted fast track designation by the U.S. FDA ...
Posted by Michael Wonder on 01 Aug 2017
The Americans who saved health insurance
1 August 2017 - Many Americans look back on the heroic political fights of the past — for suffrage, Social ...
Posted by Michael Wonder on 01 Aug 2017
Express Scripts will exclude more drugs next year, limiting patient choice to save health plans millions
31 July 2017 - Express Scripts, the nation’s largest pharmacy benefits manager, will exclude an additional 64 medicines next year ...
Posted by Michael Wonder on 01 Aug 2017
Sanders to unveil rule requiring drug companies to set fair prices
31 July 2017 - Senator Bernie Sanders will unveil a new rule forcing pharmaceutical companies to set reasonable prices for ...
Posted by Michael Wonder on 01 Aug 2017
FDA approves new targeted treatment for relapsed or refractory acute myeloid leukaemia
1 August 2017 - The U.S. FDA today approved Idhifa (enasidenib) for the treatment of adult patients with relapsed or refractory ...